Skip to main content
. Author manuscript; available in PMC: 2013 Jan 17.
Published in final edited form as: J Am Coll Cardiol. 2012 Jan 17;59(3):246–255. doi: 10.1016/j.jacc.2011.10.854

Table 1. Patient Characteristics by Diagnosis and Clinical Outcome.

Cohort Characteristics Total Cohort Patients With Clinical Events (Death or Dialysis)* Patients Without Clinical Events Patients With iAKI† Patients With pAKI, Stable CKD, or Normal Function Patients With Unclear Diagnosis‡
n 1,635 72 1,563 96 1,138 401

Demographics
 Age, yrs 64.4 ± 18.7 70.9 ± 16.9§ 64.1 ± 18.7 67.7 ± 17.6‖ 63.2 ± 18.8 67.0 ± 18.3§
 White 67.6 84.7§ 68.7 80.2‖ 68.8 61.9§
 Black 9.5 5.6 9.9 7.3 10.0 8.6
 Hispanic ethnicity 18.1 6.9§ 19.1 11.5 18.8 17.8
 Female 47.7 58.3 52.0 47.9 54.4 52.3

Admission diagnosis
 Primary renal disease 0.8 8.3 0.4 9.4 0.2 0.5
 Kidney stones or other post-renal processes 2.4 1.4 2.4 22.9 0.6 2.5
 Acute coronary syndrome/ acute myocardial infarction 3.6 0 3.8 2.1 3.7 3.7
 Decompensated congestive heart failure 8.2 15.3‖ 7.8 8.3 7.8 9.2
 Cardiac arrhythmia 3.6 2.8 3.7 3.1 3.9 3.0
 Sepsis 3.4 15.3 2.8 15.6 0.9 1.8
 Infection without sepsis 22.6 13.9 23.0 17.7 20.5 29.7
 Liver disease 2.1 11.1 1.7 9.4 1.6 1.7
 TIA or stroke 4.0 8.3 3.8 1.0 4.8 2.7
 Malignancy 4.8 15.3 4.3 12.5 4.4 4.0

Admission parameters
 Systolic blood pressure, mm Hg 137 ± 27 129 ± 28‖ 137 ± 27 129 ± 33‖ 137 ± 26 137 ± 29
 Heart rate, min−1 88 ± 21 91 ± 25 88 ± 21 92 ± 21‖ 87 ± 21 90 ± 22‖
 Shock index ≥0.8 23.8 29.9 23.5 37.6§ 21.7 26.6

Comorbid conditions
 History of CKD (stage 3 or higher)# 25.2 36.1§ 22.6 37.5 19.6 37.0
 Diabetes 29.4 37.5 29.0 36.5‖ 25.6 38.3
 Hypertension 60.9 69.4 60.5 59.4 59.3 70.0§
 Coronary artery disease 23.2 23.9 23.2 20.8 23.6 22.7
 Congestive heart failure 27.6 40.8‖ 27.0 32.6 24.2 36.0
 Peripheral vascular disease 5.6 4.2 5.7 5.2 5.3 6.6
 Cerebrovascular arterial disease 6.5 8.5 6.4 5.2 6.2 7.6

Kidney function
 Baseline sCr, mg/dl** 0.9 ± 0.4 1.0 ± 0.6‖ 0.9 ± 0.4 1.1 ± 0.6 0.9 ± 0.3 1.0 ± 0.5
 sCr at admission, mg/dl** 1.1 ± 0.8 1.9 ± 2.3 1.1 ± 0.7 2.9 ± 3.4 1.0 ± 0.5 1.2 ± 0.7
 Ratio of change in sCr level from baseline to admission** 1.2 ± 0.5 1.9 ± 1.8 1.2 ± 0.4 2.5 ± 2.6 1.1 ± 0.3 1.2 ± 0.4
 eGFR at admission, ml/min/1.73 m2 70.5 ± 33.2 43.3 ± 30.6 71.7 ± 31.7 28.8 ± 22.1 76.4 ± 31.8 63.6 ± 30.8

Clinical events
 Death 3.4 — — 21.9 1.7 4.0
 In-hospital dialysis initiation 1.5 — — 17.7 0.3 1.3
 Death without previous dialysis 2.9 — — 15.6 1.6 3.5
 Death or inpatient dialysis 4.4 — — 33.3 1.8 4.7
 ICU admission 14.4 — — 29.2 11.8 18.2§

Values are n, mean ± SD, or %.

*

Compared with patients without clinical events.

†

Compared with patients with prerenal AKI, stable CKD or normal function.

‡

Compared with all adjudicated patients.

§

p < 0.01 (t test or chi-square test, as appropriate).

‖

p < 0.05 (t test or chi-square test, as appropriate).

p < 0.001 (t test or chi-square test, as appropriate).

#

Defined by baseline eGFR <60 ml/min/1.73 m2.

**

Geometric mean and SD.

CKD = chronic kidney disease; eGFR = estimated glomerular filtration rate; iAKI = intrinsic acute kidney injury; ICU = intensive care unit; pAKI = prerenal acute kidney injury; sCr = serum creatinine; TIA = transient ischemic attack.